The widespread application of GLP-1 receptor agonists at the population level may impose significant financial pressure on pharmaceutical budgets, with modeling studies indicating that treating all eligible individuals with diabetes and obesity might need a 1020% rise in drug expenditures in several nations
A medication from an FDA-inspected outsourcing facility is going to be held to stricter standards than one made at a compounding pharmacy without FDA oversight
Kettle, A.J., et al., Oxidation contributes to low glutathione in the airways of children with cystic fibrosis
In Cusco, we recommend resting the first few hours to adjust to the altitude
Using microsimulation modeling, she evaluates cost-effectiveness and long-term outcomes to support data-driven, equitable obesity care
We next tested P5 efficacy in the DIO mouse model of pre-type 2 diabetes (obese hyperglycaemic and insulin-resistant mice)